MindMaze is a commercial-stage medical device company that develops and commercializes integrated systems for minimally invasive neurosurgical procedures. The company operates two main business segments: medical devices for neurosurgery, including the ClearPoint System for MRI-guided stereotactic procedures (targeting applications such as deep brain stimulation electrode placement, biopsies, and brain infusion), laser ablation systems for thermal therapy, and the IRRAflow System for intracranial pressure management; and biologics and drug delivery services, providing consulting and preclinical development services to pharmaceutical and biotech partners developing gene and cell therapies for brain delivery. Revenue derives from a capital equipment placement model with recurring high-margin disposable products, as well as from product sales and services related to drug delivery and consulting for pharma customers. The company serves neurosurgeons, neuro-intensivists, and hospital teams in the U.S. and international markets, with all major products holding FDA clearance or De Novo authorization and CE mark approval in Europe.